21:00:58 EDT Sat 05 Jul 2025
Enter Symbol
or Name
USA
CA



E:CYBN - CYBIN INC. - https://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  0.211.05·11.150.711.15+0.353.22.9315711.05  11.24  11.0519.46  6.9516:00:00Jul 0115 min
NEO exchange - E0.211.05·11.150.711.15+0.353.22.1231611.05  11.24  11.0519.46  6.9516:00:0015 min
Omega - O 11.05+0.252.30.11111.05  11.05  11.0511:11:0015 min
Chi-X - X 11.05+0.252.30.11111.05  11.05  11.0510:21:1415 min
CXD - D 10.800.228    Jun 0315 min
TriAct - M 10.800.4431    15 min

Recent Trades - Last 10 of 57
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00E11.150.350301 NEO Buy301 NEO BuyZ
15:59:59E11.150.3510079 CIBC1 AnonymousK
15:59:59E11.060.2630079 CIBC7 TD SecK
15:32:36E11.100.3020084 ITG847 TD SecK
15:02:54M11.150.35580 National Bank80 National BankE
14:08:09E11.150.351519 Desjardins14 Virtu ITGE
14:05:01M11.050.25180 National Bank80 National BankE
13:33:49M11.150.35114 Virtu ITG14 Virtu ITGE
13:12:11M11.050.25380 National Bank80 National BankE
13:05:29M11.050.252180 National Bank80 National BankE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-01 09:50C:CYBN11.40News ReleaseGlobal Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
2025-06-30 22:03C:CYBN11.40News ReleaseCybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-06-30 21:54C:CYBN11.40SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-30 21:54C:CYBN11.40SEDAR MD & ASEDAR MD & A
2025-06-30 21:49C:CYBN11.40SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-30 21:27C:CYBN11.40News ReleaseCybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
2025-06-13 16:51C:CYBN11.20News ReleaseCybin talks partnerships, regulatory signals
2025-06-11 07:30C:CYBN12.20News ReleaseCybin to Participate in the 2025 Psychedelic Science Conference
2025-06-03 17:02C:CYBN11.25News ReleaseCybin receives U.S. patent for CYB004 DMT program
2025-05-20 12:33C:CYBN11.80News ReleaseCybin hears FDA pushing for psychedelic therapeutics
2025-05-15 16:49C:CYBN11.80News ReleaseCybin hires Thermo Fisher for phase 3 supply of CYB003
2025-05-14 07:30C:CYBN11.80News ReleaseCybin to Participate in the Alliance Global Partners Healthcare Company Showcase
2025-05-08 17:29C:CYBNNews ReleaseCybin receives U.S. patent for its CYB003 program
2025-05-01 07:30C:CYBN11.80News ReleaseCybin to Participate at the 28th Annual Milken Institute Global Conference
2025-04-23 07:30C:CYBN11.80News ReleaseCybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
2025-04-21 17:01C:CYBN11.80News ReleaseCybin forms partnership with Osmind
2025-02-10 21:48C:CYBN13.25News ReleaseCybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-02-10 20:55C:CYBN13.25SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-10 20:49C:CYBN13.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-01-15 18:18C:CYBN13.10News ReleaseCybin launches partnership agreement with Segal Trials